Why is cardiovascular risk stratification important in hypertensive patients?

@article{ColldeTuero2012WhyIC,
  title={Why is cardiovascular risk stratification important in hypertensive patients?},
  author={Gabriel Coll-de-Tuero and Marc Saez and Antonio Rodr{\'i}guez-Poncelas and Antonia Barcel{\'o}-Rado and Susanna Vargas-Vila and Josep Garre-Olmo and Victoria Sala and Angels Sieira and Esther Gelada and Jes{\'u}s Gelado-Ferrero},
  journal={Blood pressure},
  year={2012},
  volume={21 3},
  pages={182-90}
}
BACKGROUND The aim is to evaluate whether cardiovascular (CV) risk stratification in newly diagnosed hypertensive patients according to the European Society of Hypertension (ESH) guidelines, can predict the evolution of target organ damage (TOD) using routine examinations in clinical practice during 1 year. METHODS Prospective study of recently diagnosed untreated hypertensives. At the moment of inclusion and 1 year later, urinary albumin excretion rate (UAER), blood analysis… CONTINUE READING